MAYER DAVIDSON

Summary

Affiliation: Charles R. Drew University of Medicine and Science
Country: USA

Publications

  1. ncbi request reprint Effect of a pharmacist-managed diabetes care program in a free medical clinic
    M B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, CA 90059, USA
    Am J Med Qual 15:137-42. 2000
  2. ncbi request reprint Effect of nurse-directed diabetes care in a minority population
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, California 90059, USA
    Diabetes Care 26:2281-7. 2003
  3. ncbi request reprint Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, 1731 East 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 28:1531-3. 2005
  4. ncbi request reprint The case for "outsourcing" diabetes care
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, California 90059, USA
    Diabetes Care 26:1608-12. 2003
  5. ncbi request reprint Have we got the new diagnostic criteria for diabetes and impaired glucose states right? No
    Mayer B Davidson
    Charles R Drew University of Medicine and Science, Clinical Trials Unit, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Curr Diab Rep 2:3-4. 2002
  6. ncbi request reprint The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Am J Med 118:422-5. 2005
  7. ncbi request reprint Exenatide
    Mayer B Davidson
    Charles R Drew University, Los Angeles, California 90059, USA
    Nat Rev Drug Discov 4:713-4. 2005
  8. ncbi request reprint Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, 1731 East 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 27:2260-1. 2004
  9. ncbi request reprint Effective diabetes care by a registered nurse following treatment algorithms in a minority population
    Mayer B Davidson
    Charles R Drew University, Los Angeles, CA 90059, USA
    Am J Manag Care 12:226-32. 2006
  10. ncbi request reprint Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population
    Rajiv Roy
    Clinical Trials Unit, Charles R Drew University, Los Angeles, CA 90059, USA
    Diabetes Care 27:1741-2. 2004

Research Grants

  1. CLINICAL TRIALS UNIT
    MAYER DAVIDSON; Fiscal Year: 2003
  2. Center for Urban Research Excellence in Diabetes and Metabolism
    MAYER DAVIDSON; Fiscal Year: 2007
  3. Center for Urban Research Excellence in Diabetes and Metabolism
    MAYER DAVIDSON; Fiscal Year: 2009

Detail Information

Publications66

  1. ncbi request reprint Effect of a pharmacist-managed diabetes care program in a free medical clinic
    M B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, CA 90059, USA
    Am J Med Qual 15:137-42. 2000
    ..Pharmacists following detailed algorithms can enhance this care further. Administrative and support system changes that minimize the number of missed visits might further improve diabetes care in this population...
  2. ncbi request reprint Effect of nurse-directed diabetes care in a minority population
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, California 90059, USA
    Diabetes Care 26:2281-7. 2003
    ....
  3. ncbi request reprint Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, 1731 East 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 28:1531-3. 2005
  4. ncbi request reprint The case for "outsourcing" diabetes care
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, California 90059, USA
    Diabetes Care 26:1608-12. 2003
  5. ncbi request reprint Have we got the new diagnostic criteria for diabetes and impaired glucose states right? No
    Mayer B Davidson
    Charles R Drew University of Medicine and Science, Clinical Trials Unit, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Curr Diab Rep 2:3-4. 2002
  6. ncbi request reprint The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Am J Med 118:422-5. 2005
  7. ncbi request reprint Exenatide
    Mayer B Davidson
    Charles R Drew University, Los Angeles, California 90059, USA
    Nat Rev Drug Discov 4:713-4. 2005
  8. ncbi request reprint Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, 1731 East 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 27:2260-1. 2004
  9. ncbi request reprint Effective diabetes care by a registered nurse following treatment algorithms in a minority population
    Mayer B Davidson
    Charles R Drew University, Los Angeles, CA 90059, USA
    Am J Manag Care 12:226-32. 2006
    ..To compare usual care with nurse-directed care for patients with diabetes...
  10. ncbi request reprint Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population
    Rajiv Roy
    Clinical Trials Unit, Charles R Drew University, Los Angeles, CA 90059, USA
    Diabetes Care 27:1741-2. 2004
  11. ncbi request reprint Using focus groups of older African Americans and Latinos with diabetes to modify a self-care empowerment intervention
    Catherine A Sarkisian
    Department of Medicine, Division of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095 1687, USA
    Ethn Dis 15:283-91. 2005
    ..To make cultural and age-specific modifications to a self-care empowerment intervention...
  12. ncbi request reprint More evidence to support "outsourcing" of diabetes care
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, California 90059, USA
    Diabetes Care 27:995. 2004
  13. ncbi request reprint Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients
    Piya Ballani
    Clinical Center for Research Excellence, Charles R Drew University, 1731 E 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 29:2504-5. 2006
  14. ncbi request reprint ImmunoDip: an improved screening method for microalbuminuria
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, Calif 90059, USA
    Am J Nephrol 24:284-8. 2004
    ..Current screening methods are suboptimal. This study evaluates a new office screening test for microalbuminuria that utilizes a monoclonal antibody against human serum albumin (ImmunoDip)...
  15. ncbi request reprint Clinical implications of the DREAM Study
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles R Drew University, 1731 East 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 30:418-20. 2007
  16. ncbi request reprint Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes
    Michael T Tran
    Clinical Center for Research Excellence, Charles R Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Diabetes Care 29:1395-6. 2006
  17. ncbi request reprint Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus
    Stanley H Hsia
    Charles R Drew University of Medicine and Science, Los Angeles, CA, USA
    Metabolism 53:1166-73. 2004
    ..0% to 12.0%. This study represents the first properly designed, prospective intervention trial of therapy with an Ayurvedic herbal supplement for intermediate-term glucose control in type 2 diabetes...
  18. ncbi request reprint Integrating nurse-directed diabetes management into a primary care setting
    Mayer B Davidson
    Department of Internal Medicine, Charles R Drew University of Medicine and Science, Los Angeles, CA 90059, USA
    Am J Manag Care 16:652-6. 2010
    ....
  19. ncbi request reprint Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles R Drew University, 1731 East 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 30:224-7. 2007
    ..To evaluate whether nurse-directed diabetes care reduced preventable diabetes-related urgent care/emergency room visits and hospitalizations in a minority population...
  20. pmc The impact of using a low-literacy patient education tool on process measures of diabetes care in a minority population
    Diana M Echeverry
    Charles R Drew University School of Medicine, Los Angeles, California 90059, USA
    J Natl Med Assoc 95:1074-81. 2003
    ..We conclude that although low-literacy reminder cards did improve the ordering of process measures somewhat, they were not as effective as the utilization of progress forms with specific diabetes-related measures...
  21. ncbi request reprint Lowering the criterion for impaired fasting glucose will not provide clinical benefit
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, California 90059, USA
    Diabetes Care 26:3329-30. 2003
  22. ncbi request reprint Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac event
    Diana Echeverry
    Charles R Drew University School of Medicine and Science, Clinical Center for Research Excellence, University of California, Los Angeles, CA 90059, USA
    Am J Manag Care 11:758-64. 2005
    ..To improve the treatment of risk factors of cardiovascular disease (CVD) for older patients with diabetes after a cardiac event by using a low-literacy reminder card describing these risk factors in community settings...
  23. ncbi request reprint The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: a narrative review
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles R Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Curr Diabetes Rev 3:280-6. 2007
    ....
  24. ncbi request reprint Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck
    Mayer B Davidson
    Charles Drew University, Los Angeles, CA 90059, USA
    Rev Recent Clin Trials 5:138-42. 2010
    ..This lack of benefit argues for redirecting these resources into areas of diabetes care where strong evidence exists for improving diabetes outcomes...
  25. doi request reprint Detailed treatment algorithms for effective nurse- and pharmacist-directed diabetes care: a personal approach
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles R Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Diabetes Educ 35:61-71. 2009
    ....
  26. doi request reprint Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles Drew University, 1731 East 120th Street, Los Angeles, CA 90059, United States
    Diabetes Res Clin Pract 87:415-21. 2010
    ..To determine if age and race/ethnicity affect HbA1c levels independent of glycemia...
  27. pmc Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles Drew University, Los Angeles, California 90059, USA
    Curr Opin Endocrinol Diabetes Obes 16:107-12. 2009
    ..The underlying reason given is that insulin will slow down the apoptosis of pancreatic beta-cells, which is increased in type 2 diabetes. This review will examine the clinical evidence supporting this recommendation...
  28. pmc U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients
    Mayer B Davidson
    Department of Internal Medicine, Charles Drew University, Los Angeles, California, USA
    Diabetes Care 33:281-3. 2010
    ..To describe the clinical experience and the pharmacokinetics of U-500 regular insulin in severely insulin-resistant obese type 2 diabetic patients...
  29. ncbi request reprint Counterpoint: the oral glucose tolerance test is superfluous
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, California 90059, USA
    Diabetes Care 25:1883-5. 2002
  30. ncbi request reprint Established therapies for diabetes mellitus
    Stanley H Hsia
    Charles R Drew University of Medicine and Science, Clinical Trials Unit, Los Angeles, California 90059, USA
    Curr Med Res Opin 18:s13-21. 2002
    ..Newer agents (such as the thiazolidinediones, newer insulin secretagogues, and insulin analogues) will be discussed elsewhere...
  31. pmc Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial
    Diana Echeverry
    Charles Drew University, Los Angeles, California, USA
    Diabetes Care 32:2156-60. 2009
    ..To determine whether pharmacological treatment of depression in low-income minorities with diabetes improves A1C and quality of life (QOL)...
  32. ncbi request reprint Utility of A1C for diabetes screening in the 1999 2004 NHANES population
    Catherine Buell
    Charles R Drew University, Los Angeles, California 90059, USA
    Diabetes Care 30:2233-5. 2007
  33. ncbi request reprint Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study
    Rita Pradhan
    Department of Medicine, Charles R Drew University, Los Angeles, CA, USA
    J Diabetes Complications 16:377-81. 2002
    ....
  34. ncbi request reprint Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al
    Mayer B Davidson
    Diabetes Care 28:2597; author reply 2597-8. 2005
  35. ncbi request reprint Recommendations for management of diabetes during Ramadan
    Mayer B Davidson
    Diabetes Care 29:745; author reply 746. 2006
  36. ncbi request reprint Impaired fasting glucose and impaired glucose tolerance: implications for care
    David M Nathan
    Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Diabetes Care 30:753-9. 2007
  37. doi request reprint Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Stud
    David M Nathan
    Diabetes Center, Massachusetts General Hospital, Boston, MA 02114, USA
    Diabetes Care 31:173-5. 2008
  38. doi request reprint A new look at screening and diagnosing diabetes mellitus
    Christopher D Saudek
    Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Clin Endocrinol Metab 93:2447-53. 2008
    ..This report reconsiders the criteria for diagnosing diabetes and recommends screening criteria to make case finding easier for clinicians and patients...
  39. pmc No need for the needle (at first)
    Mayer B Davidson
    Diabetes Care 31:2070-1. 2008
  40. ncbi request reprint Type-1 diabetes mellitus with insufficient serum immunoreactive insulin elevation after subcutaneous NPH-insulin injection
    Mayer B Davidson
    Diabetes Res Clin Pract 64:229. 2004
  41. ncbi request reprint Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et al
    Mayer B Davidson
    Diabetes Care 27:1846; author reply 1847-8. 2004
  42. ncbi request reprint Editor's comment: "It ain't necessarily so"
    Mayer B Davidson
    Diabetes Care 25:2116. 2002
  43. ncbi request reprint Early insulin therapy for type 2 diabetic patients: more cost than benefit
    Mayer B Davidson
    Diabetes Care 28:222-4. 2005
  44. ncbi request reprint Thiazolidinediones
    Mayer B Davidson
    N Engl J Med 352:205-7; author reply 205-7. 2005
  45. ncbi request reprint Starting insulin therapy in type 2 diabetic patients: does it really matter how?
    Mayer B Davidson
    Diabetes Care 28:494-5. 2005
  46. ncbi request reprint For the patient. Managing diabetes with cultural sensitivity and self-empowerment
    Catherine A Sarkisian
    Ethn Dis 15:351. 2005
  47. ncbi request reprint Triple therapy: definitions, application, and treating to target
    Mayer B Davidson
    Diabetes Care 27:1834-5. 2004
  48. ncbi request reprint Status of research funded by the American Diabetes Association--year 4
    Mayer B Davidson
    Diabetes 52:1588. 2003
  49. ncbi request reprint Tests of glycemia
    Mayer B Davidson
    Ann Intern Med 138:517; author reply 517. 2003
  50. ncbi request reprint Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes
    Michael Brandle
    Department of Internal Medicine, Division of Endocrinology and Metabolism, and the Michigan Diabetes Research and Training Center, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
    Diabetes Care 26:1796-801. 2003
    ..S. population with diabetes and LDL cholesterol levels > or =100 mg/dl, especially in the population with LDL cholesterol levels 100-129 mg/dl...
  51. ncbi request reprint Treatment decisions for type 2 diabetes
    Mayer B Davidson
    JAMA 287:1646-7; author reply 1647-8. 2002
  52. ncbi request reprint The effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care
    Mayer B Davidson
    Am J Manag Care 11:585; author reply 585. 2005
  53. ncbi request reprint Status of research funded by the American Diabetes Association: year 3
    Mayer B Davidson
    Diabetes Care 25:626. 2002
  54. ncbi request reprint Status of research funded by the American Diabetes Association: year 3
    Mayer B Davidson
    Diabetes 51:888. 2002
  55. ncbi request reprint Staying the course--with a few adjustments
    Mayer B Davidson
    Diabetes Care 25:1. 2002
  56. ncbi request reprint Metformin does not suppress thyrotropin
    Mayer B Davidson
    Endocr Pract 14:252-3. 2008
  57. ncbi request reprint Status of research funded by the American Diabetes Association--year 4
    Mayer B Davidson
    Diabetes Care 26:1940. 2003
  58. ncbi request reprint SF-36 and diabetes outcome measures
    Mayer B Davidson
    Diabetes Care 28:1536-7. 2005
  59. ncbi request reprint Glycemia and risk for cardiovascular disease
    Mayer B Davidson
    Ann Intern Med 142:227; author reply 227-8. 2005
  60. ncbi request reprint Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
    David M Nathan
    Diabetes Center, Massachusetts General Hospital, Boston, 02114, USA
    Diabetes Care 29:1963-72. 2006
  61. ncbi request reprint Status of research funding by the American Diabetes Association--5th and final year
    Mayer B Davidson
    Diabetes Care 27:1235. 2004
  62. ncbi request reprint Status of research funding by the American Diabetes Association--5th and final year
    Mayer B Davidson
    Diabetes 53:1403. 2004
  63. ncbi request reprint Novel risk factors for atherosclerosis
    Mayer B Davidson
    JAMA 291:301; author reply 301-2. 2004
  64. ncbi request reprint Is treatment of insulin resistance beneficial independent of glycemia?
    Mayer B Davidson
    Diabetes Care 26:3184-6. 2003
  65. ncbi request reprint Metabolic syndrome/insulin resistance syndrome/pre-diabetes: new section in diabetes care
    Mayer B Davidson
    Diabetes Care 26:3179. 2003
  66. ncbi request reprint Does the metabolic syndrome exist: response to Grundy
    Mayer B Davidson
    Diabetes Care 29:2565; author reply 2565-6. 2006

Research Grants7

  1. CLINICAL TRIALS UNIT
    MAYER DAVIDSON; Fiscal Year: 2003
    ....
  2. Center for Urban Research Excellence in Diabetes and Metabolism
    MAYER DAVIDSON; Fiscal Year: 2007
    ....
  3. Center for Urban Research Excellence in Diabetes and Metabolism
    MAYER DAVIDSON; Fiscal Year: 2009
    ..abstract_text> ..